• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较边际结构模型和 Cox 比例风险模型来估计观察性研究中时变药物使用的效果:以他汀类药物用于心血管疾病一级预防为例,来自鹿特丹研究。

Comparing a marginal structural model with a Cox proportional hazard model to estimate the effect of time-dependent drug use in observational studies: statin use for primary prevention of cardiovascular disease as an example from the Rotterdam Study.

机构信息

Department of Epidemiology, Erasmus MC - University Medical Center Rotterdam, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands,

出版信息

Eur J Epidemiol. 2014 Nov;29(11):841-50. doi: 10.1007/s10654-014-9951-y. Epub 2014 Sep 12.

DOI:10.1007/s10654-014-9951-y
PMID:25213404
Abstract

When studying the causal effect of drug use in observational data, marginal structural modeling (MSM) can be used to adjust for time-dependent confounders that are affected by previous treatment. The objective of this study was to compare traditional Cox proportional hazard models (with and without time-dependent covariates) with MSM to study causal effects of time-dependent drug use. The example of primary prevention of cardiovascular disease (CVD) with statins was examined using up to 17.7 years of follow-up from 4,654 participants of the observational prospective population-based Rotterdam Study. In the MSM model, the weight was based on measurements of established cardiovascular risk factors and co-morbidity. In general, we could not demonstrate important differences in results from the Cox models and MSM. Results from analysis on duration of statin use suggested that substantial residual confounding by indication was not accounted for during the period shortly after statin initiation. In conclusion, although on theoretical grounds MSM is an elegant technique, lack of data on the precise time-dependent confounders, such as indication of treatment or other considerations of the prescribing physician jeopardizes the calculation of valid weights. Confounding remains a hurdle in observational effectiveness research on preventive drugs with a multitude of prescription determinants.

摘要

当在观察性数据中研究药物使用的因果效应时,可以使用边缘结构模型(MSM)来调整受先前治疗影响的时变混杂因素。本研究的目的是比较传统的 Cox 比例风险模型(有和无时变协变量)与 MSM,以研究时变药物使用的因果效应。使用前瞻性观察性基于人群的鹿特丹研究中 4654 名参与者的长达 17.7 年的随访数据,考察了他汀类药物在心血管疾病(CVD)一级预防中的作用。在 MSM 模型中,权重基于已建立的心血管风险因素和合并症的测量值。一般来说,我们不能证明 Cox 模型和 MSM 的结果存在重要差异。他汀类药物使用持续时间分析的结果表明,在他汀类药物起始后不久的时期内,指示性残余混杂因素未得到充分考虑。总之,尽管从理论上讲,MSM 是一种优雅的技术,但缺乏关于确切的时变混杂因素的数据,例如治疗的指示或处方医生的其他考虑因素,这会危及有效权重的计算。混杂因素仍然是具有多种处方决定因素的预防性药物观察性效果研究中的一个障碍。

相似文献

1
Comparing a marginal structural model with a Cox proportional hazard model to estimate the effect of time-dependent drug use in observational studies: statin use for primary prevention of cardiovascular disease as an example from the Rotterdam Study.比较边际结构模型和 Cox 比例风险模型来估计观察性研究中时变药物使用的效果:以他汀类药物用于心血管疾病一级预防为例,来自鹿特丹研究。
Eur J Epidemiol. 2014 Nov;29(11):841-50. doi: 10.1007/s10654-014-9951-y. Epub 2014 Sep 12.
2
Using imputed pre-treatment cholesterol in a propensity score model to reduce confounding by indication: results from the multi-ethnic study of atherosclerosis.在倾向评分模型中使用推断的预处理胆固醇来减少指示性偏倚:来自动脉粥样硬化多民族研究的结果。
BMC Med Res Methodol. 2013 Jun 21;13:81. doi: 10.1186/1471-2288-13-81.
3
Statin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time-dependent confounding affected by previous adherence.女性中他汀类药物的依从性与急性心血管事件风险:一项考虑既往依从性所影响的时间依赖性混杂因素的队列研究。
BMJ Open. 2016 Jun 3;6(6):e011306. doi: 10.1136/bmjopen-2016-011306.
4
Impact of Statin Adherence on Cardiovascular Morbidity and All-Cause Mortality in the Primary Prevention of Cardiovascular Disease: A Population-Based Cohort Study in Finland.他汀类药物依从性对心血管疾病一级预防中心血管发病率和全因死亡率的影响:芬兰一项基于人群的队列研究
Value Health. 2015 Sep;18(6):896-905. doi: 10.1016/j.jval.2015.06.002. Epub 2015 Aug 5.
5
Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.意大利日常临床实践中他汀类药物治疗依从性与非致命性缺血性心脏病风险的回顾性数据库分析结果。
Clin Ther. 2010 Feb;32(2):300-10. doi: 10.1016/j.clinthera.2010.02.004.
6
[Marginal structural models application to estimate the effects of antiretroviral therapy in 5 cohorts of HIV seroconverters].[应用边际结构模型评估抗逆转录病毒疗法对5组HIV血清转化者的疗效]
Gac Sanit. 2007 Jan-Feb;21(1):76-83. doi: 10.1016/s0213-9111(07)71974-x.
7
Modeling the 4D Study: statins and cardiovascular outcomes in long-term hemodialysis patients with diabetes.建模 4D 研究:糖尿病长期血液透析患者中的他汀类药物与心血管结局。
Clin J Am Soc Nephrol. 2010 May;5(5):856-66. doi: 10.2215/CJN.07161009. Epub 2010 Mar 25.
8
Comparative effectiveness of statin plus fibrate combination therapy and statin monotherapy in patients with type 2 diabetes: use of propensity-score and instrumental variable methods to adjust for treatment-selection bias.他汀类药物联合贝特类药物治疗与他汀类药物单药治疗 2 型糖尿病患者的疗效比较:使用倾向评分和工具变量法调整治疗选择偏倚。
Pharmacoepidemiol Drug Saf. 2012 May;21(5):470-84. doi: 10.1002/pds.3261. Epub 2012 Mar 28.
9
Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study.比较 ACC/AHA 和 ESC 指南建议,基于临床试验证据,在心血管疾病一级预防中使用他汀类药物:来自基于人群的鹿特丹研究的结果。
JAMA Cardiol. 2016 Sep 1;1(6):708-13. doi: 10.1001/jamacardio.2016.1577.
10
Time to improve statin prescription guidelines in low-risk patients?是时候改进低风险患者的他汀类药物处方指南了吗?
Eur J Prev Cardiol. 2017 Jul;24(10):1064-1070. doi: 10.1177/2047487317698585. Epub 2017 Mar 14.

引用本文的文献

1
Adverse Impact of Sodium Bicarbonate Administration on Multiple Outcomes in Acute Pancreatitis Patients With Hyperlactatemia.碳酸氢钠给药对高乳酸血症急性胰腺炎患者多项结局的不良影响。
Pancreas. 2024 Jan 1;53(1):e62-e68. doi: 10.1097/MPA.0000000000002275. Epub 2023 Nov 24.
2
Impact of early heparin therapy on outcomes in patients with solid malignancy associated sepsis: a marginal structural model causal analyse.早期肝素治疗对实体恶性肿瘤相关性脓毒症患者预后的影响:边际结构模型因果分析
Front Pharmacol. 2023 Dec 4;14:1281235. doi: 10.3389/fphar.2023.1281235. eCollection 2023.
3
Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy.

本文引用的文献

1
Application of marginal structural models in pharmacoepidemiologic studies: a systematic review.边际结构模型在药物流行病学研究中的应用:一项系统评价。
Pharmacoepidemiol Drug Saf. 2014 Jun;23(6):560-71. doi: 10.1002/pds.3569. Epub 2014 Jan 24.
2
The Rotterdam Study: 2014 objectives and design update.《鹿特丹研究:2014 年目标与设计更新》
Eur J Epidemiol. 2013 Nov;28(11):889-926. doi: 10.1007/s10654-013-9866-z. Epub 2013 Nov 21.
3
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
早期肝素治疗对脓毒症诱导的凝血病重症患者预后的有效性。
Front Pharmacol. 2023 May 15;14:1173893. doi: 10.3389/fphar.2023.1173893. eCollection 2023.
4
Instrumental variable estimation of the marginal structural Cox model for time-varying treatments.用于时变治疗的边际结构Cox模型的工具变量估计
Biometrika. 2021 Dec 8;110(1):101-118. doi: 10.1093/biomet/asab062. eCollection 2023 Mar.
5
Clinical effectiveness of sodium bicarbonate therapy on mortality for septic patients with acute moderate lactic acidosis.碳酸氢钠治疗对急性中度乳酸酸中毒脓毒症患者死亡率的临床疗效。
Front Pharmacol. 2023 Jan 9;13:1059285. doi: 10.3389/fphar.2022.1059285. eCollection 2022.
6
Effectiveness of sodium bicarbonate infusion on mortality for elderly septic patients with acute metabolic acidosis.碳酸氢钠输注对老年急性代谢性酸中毒脓毒症患者死亡率的影响。
Front Pharmacol. 2022 Sep 13;13:974271. doi: 10.3389/fphar.2022.974271. eCollection 2022.
7
Adherence to -Defined Diet Quality Indices Throughout the Early Disease Course Is Associated With Survival in Head and Neck Cancer Survivors: An Application Involving Marginal Structural Models.在头颈癌幸存者疾病早期过程中坚持特定饮食质量指标与生存相关:一项涉及边际结构模型的应用研究
Front Nutr. 2022 Apr 25;9:791141. doi: 10.3389/fnut.2022.791141. eCollection 2022.
8
Effectiveness of sodium bicarbonate infusion on mortality in septic patients with metabolic acidosis.碳酸氢钠输注对合并代谢性酸中毒的脓毒症患者死亡率的影响。
Intensive Care Med. 2018 Nov;44(11):1888-1895. doi: 10.1007/s00134-018-5379-2. Epub 2018 Sep 25.
9
Statin Treatment and Clinical Outcomes of Heart Failure Among Africans: An Inverse Probability Treatment Weighted Analysis.他汀类药物治疗与非洲人心力衰竭的临床结局:逆概率处理加权分析。
J Am Heart Assoc. 2017 Apr 1;6(4):e004706. doi: 10.1161/JAHA.116.004706.
10
Caution: work in progress : While the methodological "revolution" deserves in-depth study, clinical researchers and senior epidemiologists should not be disenfranchised.注意:工作进行中:虽然方法学“革命”值得深入研究,但临床研究人员和资深流行病学家不应被剥夺权利。
Eur J Epidemiol. 2016 Jun;31(6):535-9. doi: 10.1007/s10654-016-0181-3. Epub 2016 Jul 14.
2013年美国心脏病学会/美国心脏协会成人降低动脉粥样硬化性心血管风险的血胆固醇治疗指南:美国心脏病学会/美国心脏协会实践指南工作组报告
Circulation. 2014 Jun 24;129(25 Suppl 2):S1-45. doi: 10.1161/01.cir.0000437738.63853.7a. Epub 2013 Nov 12.
4
Statins for the primary prevention of cardiovascular disease.他汀类药物用于心血管疾病的一级预防。
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD004816. doi: 10.1002/14651858.CD004816.pub5.
5
Personalized prediction of lifetime benefits with statin therapy for asymptomatic individuals: a modeling study.为无症状个体进行他汀类药物治疗的终生获益的个体化预测:一项建模研究。
PLoS Med. 2012;9(12):e1001361. doi: 10.1371/journal.pmed.1001361. Epub 2012 Dec 27.
6
Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute.心血管疾病比较效果研究的未来方向:国家心肺血液研究所赞助的研讨会报告。
J Am Coll Cardiol. 2012 Aug 14;60(7):569-80. doi: 10.1016/j.jacc.2011.12.057. Epub 2012 Jul 11.
7
Aspirin in the primary prevention of cardiovascular disease in the Women's Health Study: effect of noncompliance.阿司匹林在妇女健康研究中的心血管疾病一级预防中的应用:不依从的影响。
Eur J Epidemiol. 2012 Jun;27(6):431-8. doi: 10.1007/s10654-012-9702-x. Epub 2012 Jun 15.
8
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).《欧洲临床实践心血管疾病预防指南》(2012年版)。欧洲心脏病学会及其他学会心血管疾病预防临床实践联合工作组第五版(由九个学会的代表及特邀专家组成)。
Eur Heart J. 2012 Jul;33(13):1635-701. doi: 10.1093/eurheartj/ehs092. Epub 2012 May 3.
9
Why we still need randomized trials to compare effectiveness.为什么我们仍然需要随机试验来比较有效性。
N Engl J Med. 2012 Apr 19;366(16):1538-40. doi: 10.1056/NEJMe1202866. Epub 2012 Mar 27.
10
Trends in stroke incidence rates and stroke risk factors in Rotterdam, the Netherlands from 1990 to 2008.1990 年至 2008 年荷兰鹿特丹的卒中发病率和卒中危险因素趋势。
Eur J Epidemiol. 2012 Apr;27(4):287-95. doi: 10.1007/s10654-012-9673-y. Epub 2012 Mar 17.